A multiplex PCR predictor for aCGH success of FFPE samples

por van Beers, E H, Joosse, S A, Ligtenberg, M J, Fles, R, Hogervorst, F B L, Verhoef, S, Nederlof, P M
Publicado 2006

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers

por Lips, E H, Mulder, L, Oonk, A, van der Kolk, L E, Hogervorst, F B L, Imholz, A L T, Wesseling, J, Rodenhuis, S, Nederlof, P M
Publicado 2013

Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach

por Gille, J J P, Hogervorst, F B L, Pals, G, Wijnen, JTh, van Schooten, R J, Dommering, C J, Meijer, G A, Craanen, M E, Nederlof, P M, de Jong, D, McElgunn, C J, Schouten, J P, Menko, F H
Publicado 2002

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

por Vollebergh, M. A., Lips, E. H., Nederlof, P. M., Wessels, L. F. A., Schmidt, M. K., van Beers, E. H., Cornelissen, S., Holtkamp, M., Froklage, F. E., de Vries, E. G. E., Schrama, J. G., Wesseling, J., van de Vijver, M. J., van Tinteren, H., de Bruin, M., Hauptmann, M., Rodenhuis, S., Linn, S. C.
Publicado 2011